Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Engimmune Therapeutics logo

Engimmune Therapeutics

Recent Finacing

Seed

Recent Raise

$15.9M

Engimmune Therapeutics is a biotech developing TCR-T and soluble TCR therapeutics using genome editing, high-throughput functional screening, deep sequencing and machine learning for oncology and autoimmune diseases.

Founded 2021
Basel-Stadt, Switzerland
11-50
Private
engimmune.com

Highlights

Focus Areas

Biotechnology
Therapeutics

Recent Investors

Pureos Bioventures logo
BaseLaunch logo
Novo Holdings logo

Financials

$15.9M

Total Raised

1

Funding round

3

Investors


Team

Upgrade to view the team

See the team members at Engimmune Therapeutics.